NCT01303328View on ClinicalTrials.gov

Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Uterine Cervical NeoplasiaCervix Intraepithelial Neoplasia
Interventions
DRUG

C1

Local application of the experimental gel or placebo gel.

Trial Locations (9)

1000

Hôpital Saint Pierre, Brussels

1020

CHU Brugmann, Brussels

1050

HIS Ixelles, Ixelles-Elsene

1070

Hôpital Erasme, Brussels

4000

CHR Citadelle, Liège

4032

CHU ND des Bruyères, Chênée

6000

CHU Charleroi Hôpital Civil, Charleroi

6110

CHU Charleroi Site André Vésale, Montigny-le-Tilleul

7100

CHU Tivoli, La Louvière

Sponsors
All Listed Sponsors
lead

Mithra Pharmaceuticals

INDUSTRY